Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Chern‐En Chiang et al.|New England Journal of Medicine|2019Cited by 6.8k
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Richard Peto, Christina Reith et al.|The Lancet|2016Cited by 1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
ACCF/AHA Clinical Practice Guideline Methodology Summit ReportAlice K. Jacobs, Mark R. Somerfield, Frederick G. Kushner et al.|Journal of the American College of Cardiology|2012Cited by 176
ACCF/AHA Clinical Practice Guideline Methodology Summit ReportAlice K. Jacobs, Frederick G. Kushner, Steven M. Ettinger et al.|Circulation|2012Cited by 103